Clinical trial

US: Diabetic Macular Edema (DME)

We are looking for individuals with Diabetic Macular Edema (DME), between 18 and 75 years old, who have never had treatment for DME or have had some treatment for DME with a type of drug called an “anti-VEGF” medicine to take part in new clinical trial in United States. The aim of this clinical trial is to gain better understanding of the investigational drug, as a possible treatment for individuals with DME.

  • Location: US
  • Date: As soon as possible
  • Incentive: To be disclosed by the client
  • Availability: 30 slots available